engitix.com Open in urlscan Pro
160.153.131.153  Public Scan

Form analysis
0 forms found in the DOM

Text Content

 * LinkedIn

 * Contact Us

image/svg+xml
 * About Us
   * About Us
   * Leadership
   * Board of Directors
   * Scientific Advisors
 * THE ECM Platform
   * Overview
   * Our Platform
   * The Extracellular Matrix
 * Programmes
 * Partnering
 * Media Centre
   * Press Releases
   * In The News
   * Events
   * Publications
 * Careers – Life at Engitix
 * Menu Menu




 * BEYOND THE CELLS
   
   Decoding the ECM to develop effective treatments for fibrotic diseases and
   solid tumours


 * PATIENT-CENTRIC APPROACH
   
   Accelerating the translation of discoveries from the bench to the bedside


 * FORGING INDUSTRY PARTNERSHIPS
   
   Expanding opportunities for creating new therapeutic classes for treating
   fibrosis and cancer indications


 * ADVANCING OUR DISCOVERY-STAGE PIPELINE
   
   Bringing novel assets towards the clinic to address patients high unmet needs

PreviousNext
1234



OUR PLATFORM

We are decoding the role of the extracellular matrix (ECM) in health and disease
to discover new drug targets, biomarkers, and novel therapeutic strategies to
improve the management of fibrotic diseases and solid tumours.

Learn more



OUR PIPELINE

The assets being developed in our discovery stage portfolio target
disease-specific changes in the bioactivity and deposition of ECM proteins, with
the aim of improving clinical outcomes in patients with fibrosis and solid
tumours.

Learn more



OUR PARTNERSHIPS

Agreements with Takeda Pharmaceuticals and Dompé Farmaceutici aim to create
value for Engitix and our partners through the discovery of effective therapies
for patients with fibrotic diseases and solid tumours.

Learn more




OUR PEOPLE

Our ambitious and entrepreneurial team has a wealth of scientific and clinical
expertise on the role of the extracellular matrix in chronic diseases and a
track record of delivering molecules into the clinic.

Meet the team



LATEST NEWS

 * Engitix Announces Appointment of Matthew Edwards Ph.D., as SVP Discovery and
   Emma Huang Ph.D., as VP Data Sciences 21 May 2024
 * Engitix Announces Appointment of Christopher Stevenson Ph.D., as Chief
   Scientific Officer 5 September 2023
 * Engitix Announces Appointment of Sonia Quaratino, M.D., Ph.D., as Independent
   Non-executive Director 9 May 2023

Read all our news

Proprietary in vitro 3D tissue specific and disease specific screening

OUR PROGRAMMES

We are developing a portfolio of programmes in fibrosis and solid tumours

Learn more

SEE OUR PARTNERSHIPS

We work with pharma and biotech partners to utilise the full discovery potential
of our platform

Learn more
London, UK
4th Floor, The WestWorks,
195 Wood Lane,
London W12 7FQ,
United Kingdom
Registered Office
21 Lombard Street, London, EC3V 9AH
© Engitix 2024

 * Privacy Policy

 * 
 * 

Scroll to top


This site uses session cookies only. These enable core functionality and
accessibility. You may disable these by changing your browser settings, but this
may affect how the website functions.

Continue


COOKIE AND PRIVACY SETTINGS





How we use cookies
Essential Website Cookies
Other external services
Privacy Policy
How we use cookies

We may request cookies to be set on your device. We use cookies to let us know
when you visit our websites, how you interact with us, to enrich your user
experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change
some of your preferences. Note that blocking some types of cookies may impact
your experience on our websites and the services we are able to offer.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available
through our website and to use some of its features.

Because these cookies are strictly necessary to deliver the website, refusing
them will have impact how our site functions. You always can block or delete
cookies by changing your browser settings and force blocking all cookies on this
website. But this will always prompt you to accept/refuse cookies when
revisiting our site.

We fully respect if you want to refuse cookies but to avoid asking you again and
again kindly allow us to store a cookie for that. You are free to opt out any
time or opt in for other cookies to get a better experience. If you refuse
cookies we will remove all set cookies in our domain.

We provide you with a list of stored cookies on your computer in our domain so
you can check what we stored. Due to security reasons we are not able to show or
modify cookies from other domains. You can check these in your browser security
settings.

Check to enable permanent hiding of message bar and refuse all cookies if you do
not opt in. We need 2 cookies to store this setting. Otherwise you will be
prompted again when opening a new browser window or new a tab.
Click to enable/disable essential site cookies.
Other external services

We also use different external services like Google Webfonts, Google Maps, and
external Video providers. Since these providers may collect personal data like
your IP address we allow you to block them here. Please be aware that this might
heavily reduce the functionality and appearance of our site. Changes will take
effect once you reload the page.

Google Webfont Settings:

Click to enable/disable Google Webfonts.

Google Map Settings:

Click to enable/disable Google Maps.

Google reCaptcha Settings:

Click to enable/disable Google reCaptcha.

Vimeo and Youtube video embeds:

Click to enable/disable video embeds.
Privacy Policy

You can read about our cookies and privacy settings in detail on our Privacy
Policy Page.

Privacy Policy
Hide notification only
X